Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | HPGD | P15428 | 2/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | CRHBP | P24387 | 2/20 | 0.36 |
| ▸ | CRHR2 | Q13324 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | ACP1 | P24666 | 1/20 | 0.33 |
| ▸ | CDC25B | P30305 | 1/20 | 0.33 |
| ▸ | APP | P05067 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12216676 | 0.94 | APP (0.33) | PTPN1ACP1CDC25BAPP | |
| SCHEMBL12715203 | 0.94 | APP (0.33) | PTPN1ACP1CDC25BAPP | |
| SCHEMBL12715200 | 0.92 | APP (0.34) | ALDH1A1KMT2ACYP1A2CYP3A4HPGD | |
| SCHEMBL12715425 | 0.92 | APP (0.34) | ALDH1A1KMT2ACYP1A2CYP3A4HPGD | |
| SCHEMBL13911143 | 0.91 | APP (0.32) | APP | |
| SCHEMBL12715323 | 0.89 | APP (0.37) | APP | |
| SCHEMBL12715131 | 0.89 | APP (0.34) | APP | |
| SCHEMBL12715209 | 0.89 | APP (0.34) | APP | |
| SCHEMBL12715180 | 0.88 | APP (0.35) | ALDH1A1KMT2AHPGDMEN1PTPN1 | |
| SCHEMBL13385115 | 0.87 | APP (0.32) | APP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7924697-B2 | Optical information recording medium, image-recording method and method of utilizing a dye | FUJIFILM CORPORATION (JP) | 2011-04-12 | — | — | US | disclosed |
| US-7924697-B2 | Optical information recording medium, image-recording method and method of utilizing a dye | FUJIFILM CORPORATION (JP) | 2011-04-12 | — | — | US | disclosed |
| US-20090092024-A1 | OPTICAL INFORMATION RECORDING MEDIUM, IMAGE-RECORDING METHOD AND METHOD OF UTILIZING A DYE | FUJIFILM CORPORATION (JP) | 2009-04-09 | — | — | US | disclosed |
| US-20090092024-A1 | OPTICAL INFORMATION RECORDING MEDIUM, IMAGE-RECORDING METHOD AND METHOD OF UTILIZING A DYE | FUJIFILM CORPORATION (JP) | 2009-04-09 | — | — | US | disclosed |
| US-20080090174-A1 | Novel Oxonol Dye Compounds and Optical Information Recording Medium | FUJIFILM CORPORATION (JP) | 2008-04-17 | — | — | US | disclosed |
| US-20080090174-A1 | Novel Oxonol Dye Compounds and Optical Information Recording Medium | FUJIFILM CORPORATION (JP) | 2008-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080090174-A1 | Novel Oxonol Dye Compounds and Optical Information Recording Medium | KCNB1, KCNMB1, HCN2 | ALDH1A1 445/4885KMT2A 2987/4885CYP1A2 1328/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.